This brand name is authorized in Netherlands, United Kingdom
The drug AMFEXA contains one active pharmaceutical ingredient (API):
1
Dexamfetamine
UNII JJ768O327N - DEXTROAMPHETAMINE SULFATE
|
Amphetamines are non-catecholamine, sympathomimetic amines with CNS stimulant activity. Peripheral actions include elevations of systolic and diastolic blood pressures and weak bronchodilator and respiratory stimulant action. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
AMFEXA Tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
N06BA02 | Dexamfetamine | N Nervous system → N06 Psychoanaleptics → N06B Psychostimulants, agents used for ADHD and nootropics → N06BA Centrally acting sympathomimetics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 307425, 335897, 335902 |
Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 106534 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.